These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29210063)

  • 1. Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome.
    Rickli A; Liakoni E; Hoener MC; Liechti ME
    Br J Pharmacol; 2018 Feb; 175(3):532-543. PubMed ID: 29210063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects.
    Baldo BA
    Arch Toxicol; 2018 Aug; 92(8):2457-2473. PubMed ID: 29916050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review.
    Baldo BA; Rose MA
    Br J Anaesth; 2020 Jan; 124(1):44-62. PubMed ID: 31653394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of opioids on human serotonin transporters.
    Barann M; Stamer UM; Lyutenska M; Stüber F; Bönisch H; Urban B
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):43-9. PubMed ID: 25332055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the norepinephrine transporter (NET) inhibition on μ-opioid receptor (MOR)-induced anti-nociception in a bone cancer pain model.
    Ono H; Nakamura A; Kanbara T; Minami K; Shinohara S; Sakaguchi G; Kanemasa T
    J Pharmacol Sci; 2014; 125(3):264-73. PubMed ID: 24965165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of opioids in surface and wastewaters by LC/QTOF-MS using retrospective data analysis.
    Campos-Mañas MC; Ferrer I; Thurman EM; Sánchez Pérez JA; Agüera A
    Sci Total Environ; 2019 May; 664():874-884. PubMed ID: 30769311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function.
    Zhao Y; Sun L
    J Clin Neurosci; 2008 Nov; 15(11):1264-9. PubMed ID: 18815045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids.
    Olson KM; Duron DI; Womer D; Fell R; Streicher JM
    PLoS One; 2019; 14(6):e0217371. PubMed ID: 31170174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic analysis and data mining of opioid-related adverse events submitted to the FAERS database.
    Le H; Hong H; Ge W; Francis H; Lyn-Cook B; Hwang YT; Rogers P; Tong W; Zou W
    Exp Biol Med (Maywood); 2023 Nov; 248(21):1944-1951. PubMed ID: 38158803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice.
    Fox MA; Jensen CL; Murphy DL
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1055-65. PubMed ID: 19275775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons.
    Sadeghi M; Tzschentke TM; Christie MJ
    Br J Pharmacol; 2015 Jan; 172(2):460-8. PubMed ID: 24372103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
    Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
    Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
    Kolaczynska KE; Thomann J; Hoener MC; Liechti ME
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity.
    Baldo BA
    Arch Toxicol; 2021 Aug; 95(8):2627-2642. PubMed ID: 33974096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
    Feng XQ; Zhu LL; Zhou Q
    J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
    Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fatal poisonings by prescription opioids.
    Häkkinen M; Launiainen T; Vuori E; Ojanperä I
    Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.